These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Recombinant adeno-associated virus delivers human factor IX in mice. Stewart A Mol Med Today; 1997 Sep; 3(9):368. PubMed ID: 9302683 [No Abstract] [Full Text] [Related]
13. Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues. Leebeek FWG; Miesbach W Blood; 2021 Sep; 138(11):923-931. PubMed ID: 34232980 [TBL] [Abstract][Full Text] [Related]
14. Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formation. Scott DW; Lozier JN Br J Haematol; 2012 Feb; 156(3):295-302. PubMed ID: 22055221 [TBL] [Abstract][Full Text] [Related]
15. Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial. Monahan PE; Sun J; Gui T; Hu G; Hannah WB; Wichlan DG; Wu Z; Grieger JC; Li C; Suwanmanee T; Stafford DW; Booth CJ; Samulski JJ; Kafri T; McPhee SW; Samulski RJ Hum Gene Ther; 2015 Feb; 26(2):69-81. PubMed ID: 25419787 [TBL] [Abstract][Full Text] [Related]
16. Current and future prospects for hemophilia gene therapy. Ward P; Walsh CE Expert Rev Hematol; 2016 Jul; 9(7):649-59. PubMed ID: 27153210 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy in an era of emerging treatment options for hemophilia B. Monahan PE J Thromb Haemost; 2015 Jun; 13 Suppl 1(0 1):S151-60. PubMed ID: 26149016 [TBL] [Abstract][Full Text] [Related]
19. Immune responses to AAV capsid: are mice not humans after all? Herzog RW Mol Ther; 2007 Apr; 15(4):649-50. PubMed ID: 17372595 [No Abstract] [Full Text] [Related]